These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16899623

  • 1. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
    Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M.
    Clin Cancer Res; 2006 Aug 01; 12(15):4720-9. PubMed ID: 16899623
    [Abstract] [Full Text] [Related]

  • 2. Antisense to cyclin D1 inhibits VEGF-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
    Pestell RG, Li Z.
    Clin Cancer Res; 2006 Aug 01; 12(15):4459-62. PubMed ID: 16899588
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK, Poon RT, Yuen AP, Ling MT, Wang XH, Wong YC, Guan XY, Man K, Tang ZY, Fan ST.
    Clin Cancer Res; 2006 Dec 01; 12(23):6910-9. PubMed ID: 17145808
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
    Shintani M, Okazaki A, Masuda T, Kawada M, Ishizuka M, Doki Y, Weinstein IB, Imoto M.
    Anticancer Res; 2002 Dec 01; 22(2A):639-47. PubMed ID: 12014632
    [Abstract] [Full Text] [Related]

  • 5. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G, Gao L, Birklé S, Yu RK.
    Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051
    [Abstract] [Full Text] [Related]

  • 6. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 7. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 8. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 9. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 10. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
    Frischer JS, Huang J, Serur A, Kadenhe-Chiweshe A, McCrudden KW, O'Toole K, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ.
    Int J Oncol; 2004 Sep 15; 25(3):549-53. PubMed ID: 15289855
    [Abstract] [Full Text] [Related]

  • 11. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES.
    Clin Cancer Res; 2005 Apr 01; 11(7):2662-9. PubMed ID: 15814647
    [Abstract] [Full Text] [Related]

  • 12. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
    Holloway SE, Beck AW, Shivakumar L, Shih J, Fleming JB, Brekken RA.
    Ann Surg Oncol; 2006 Aug 01; 13(8):1145-55. PubMed ID: 16791450
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
    Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A.
    Mol Cell Endocrinol; 2007 Jan 29; 264(1-2):74-81. PubMed ID: 17101211
    [Abstract] [Full Text] [Related]

  • 14. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL.
    Clin Cancer Res; 2006 Mar 15; 12(6):1928-35. PubMed ID: 16551879
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 16. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA, Nambiar D, Pal A, Agarwal R, Singh RP.
    Carcinogenesis; 2012 Feb 01; 33(2):385-93. PubMed ID: 22139440
    [Abstract] [Full Text] [Related]

  • 17. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R.
    Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869
    [Abstract] [Full Text] [Related]

  • 18. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476
    [Abstract] [Full Text] [Related]

  • 19. A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells.
    Akahane M, Akahane T, Shah A, Okajima E, Thorgeirsson UP.
    Anticancer Res; 2005 Sep 06; 25(2A):701-7. PubMed ID: 15868899
    [Abstract] [Full Text] [Related]

  • 20. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B, Zhang Y, Luo G, Li L, Zhang J.
    Anat Rec (Hoboken); 2009 May 06; 292(5):633-9. PubMed ID: 19382240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.